These dashboards give clinicians, researchers, and policymakers an ongoing view of how prescribing patterns and population health are moving together. Obesity contributes to cardiovascular disease, type 2 diabetes, certain cancers, and other chronic conditions
Novo Nordisks Peter Johannsen, MD, highlighted the biological signals observed and acknowledged the clinical limitations: subgroup analyses did not reveal meaningful benefit, and any potential responder group would be very small
Association of serum lipoprotein (a) levels and coronary atheroma volume by intravascular ultrasound
2013;304:G111727
Ozempic, Rybelsus, and Victoza are approved only for type 2 diabetes prescribing them for weight loss in non-diabetic patients is legal off-label practice, but insurance coverage for that indication is unlikely